STAT+: David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity
Amid a contentious bankruptcy court trial, a member of the Sackler family that owns Purdue…
Category: Biotech
STAT+: Startup Spotlight: Vigil Neuroscience hopes to eventually target the rare disease ALSP
Vigil Neuroscience has revealed the first condition that it will target: a rare, genetic neurodegenerative…
Opinion: Listen: An ENT physician & an advocate on the high monetary and social costs of hearing loss
Although hearing loss is a common aging-related problem, affecting two in three Americans over age…
Opinion: Waiving intellectual property rights would compromise global vaccination efforts
The resurgence of Covid-19 cases in the United States and around the world, in large…
Opinion: Scientific, moral imperatives underlie the ARPA-H mandate to include rare disorders
The response to Covid-19 by the biomedical research community in the U.S. and around the…
STAT+: Sesen Bio trial of cancer drug marked by misconduct and worrisome side effects, documents show
The clinical trial of a cancer drug rejected by the Food and Drug Administration last…
‘It’s soul-draining’: Health workers deployed to Covid hot zones are overwhelmed by deaths among the unvaccinated
BATON ROUGE, La. — Bren Ingle watched through a set of twin glass doors as…
STAT+: As use of widely prescribed stimulants increases, experts see troubling parallels to opioid crisis
A new study found that the number of adults who used two widely prescribed stimulants…
.jpg)
A unicorn in women’s health & machine learning skepticism
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Verily makes its first major acquisition as it looks to transform clinical trials
On the heels of a series of prominent recent hires, Verily announced plans on Tuesday…
STAT+: Former Medivation exec charged with insider trading after buying stock ‘within minutes’ of learning of a deal
Just days before Pfizer (PFE) announced plans to acquire Medivation six years ago, the former…
STAT+: STAT+ Conversation: Recapping HIMSS21 and looking ahead
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Roche reports Actemra shortages due to Delta variant; J&J exports Covid-19 shots made in Africa to Europe
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: With $110 million and a boost from Oprah, maternal health startup Maven hits $1 billion valuation
On Tuesday, maternal and family virtual care platform Maven raised $110 million in late-stage financing…
U.S. expected to recommend Covid-19 vaccine booster shots for all
WASHINGTON — U.S. experts are expected to recommend Covid-19 vaccine boosters for all Americans, regardless…
Opinion: A ‘great listening’ to patients could be a powerful legacy of the pandemic
A lasting memorial may be emerging for the millions of people who will have tragically…
Opinion: Cannabis legalization must address medical use, not just recreational use
Legislation to legalize cannabis at the federal level recently proposed by Sen. Chuck Schumer (D-N.Y.)…
What’s safe to do during summer’s Covid surge? STAT asked public health experts about their own plans
With Covid-19 cases and hospitalizations spiking around the country, dreams of a summer like those…
STAT+: Discovery of rare mutation in a brain protein adds fuel to debate over cause of Alzheimer’s disease
In 2014, two siblings came to see Lena Kilander about some of the problems they’d…
STAT+: Pharmalittle: Merck is latest drug maker to end 340B discounts; ‘fractionation’ is promoted to stretch Covid-19 vaccines
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: The pandemic made clear who doesn’t get to breathe clean air. Now what?
The Covid-19 pandemic exposed deep-seated inequities in everything from safe working conditions and affordable health…
Opinion: A country-wide collaboration to address the maternal health crisis
After languishing in the background for far too long, the shockingly high rate of complications…
Scientists unlock clues to determining how safe vaccinated people are from Covid-19
Imagine peering into people’s blood and being able to pick up a simple marker of…
.jpg)
At a leading health tech conference, enthusiasm for machine learning mixes with calls for greater scrutiny
Any digital health conference features its share of machine learning evangelism. Technology executives give fervent…
‘Stuck in a cul-de-sac’: Researchers are finally breaking away from the central dogma of depression
Geoffrey Attardo first tried Prozac to treat his depression when he was doing postdoctoral research…
The fine print: Understanding the new policy authorizing extra Covid vaccine doses for the immunocompromised
This much is clear: Some people in the United States with medical conditions that have…
Elective surgeries are being delayed again. Doctors want to handle it differently this time
In the past month, Tampa’s BayCare Health System has seen a tenfold increase in Covid-19…
Facebook and YouTube execs say removing Covid-19 misinformation isn’t enough
New falsehoods have emerged to match every stage of pandemic response. Unquestionably, that misinformation has…
STAT+: Pharmalittle: Pfizer says ‘trust us’ when it comes to a Covid-19 booster; FDA OKs extra dose of the mRNA shots for some people
And so, another working week will soon come to an end. Not a moment too…
Opinion: To protect from lab leaks, we need ‘banal’ safety rules, not anti-terrorism measures
“How did it start?” is among the many questions raised by the Covid-19 pandemic. Answering…
Opinion: Medically, legally, and morally, emergency departments cannot ignore addiction care
“My son Michael asked for help with his addiction to heroin,” a mother wrote in…
For undocumented students, a community to help them build health careers
When Denisse Rojas entered college, her path to becoming a doctor started with a lot…
Anti-aging foundation’s CEO left amid an investigation of co-founder Aubrey de Grey
The CEO of the SENS Research Foundation left his job and seat on the organization’s…
FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised
The Food and Drug Administration on Thursday authorized the administration of an additional dose of…
Listen: Biden’s drug pricing plan, Wall Street’s Alzheimer’s fixation, & daily 5 a.m. alarms
Can drug pricing help Democrats keep the Senate? Why is there still no nominee for…
STAT+: Ellis Unger, an outspoken FDA veteran, resigns
WASHINGTON — A top FDA official known for speaking out against controversial drug approval decisions,…
STAT+: As Bluebird backpedals from Europe, small gene and cell therapy players face tough hurdles
After Bluebird Bio (BLUE) announced plans this week to end commercial operations in Europe, the…
Amazon and Google reawaken sleep tracking & WHO calls for a global misinfo plan
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: New immunotherapy approach wiped out tumors in two patients with advanced lung cancer, study reports
Drugs called immune checkpoint inhibitors have transformed treatment of many types of tumors, but metastatic…
STAT+: Pharmalittle: Biden pushes Congress to let Medicare negotiate drug prices; National Academies failed to disclose pharma-friendly committee ties
Rise and shine, another busy day is on the way. And it will be steamy…
Gene therapy’s next steps
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET…
In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices
President Biden on Thursday took his most concrete action to date on prescription drug prices,…
Opinion: Congress should fix FDA’s accelerated approval program for the next 30 years
The Food and Drug Administration’s approval of the Alzheimer’s drug Aduhelm has sparked a broader…
Opinion: STAT+: To ensure equity and accuracy, clinical research must reflect the diversity of patients
In the journey from lab to label for a new and promising treatment, clinical research…
The decision to pull loved ones out of nursing homes when the pandemic hit was a great alternative — for those who could afford it
Every night since March 2020, Brianna Grech has ended her day the same way: She…
Opinion: Doctors pledge to do no harm. The entire health care sector should do the same by battling climate change
The alarming new report, “Climate Change 2021,” from the U.N. Intergovernmental Panel on Climate Change…
Anti-aging research pioneer Aubrey de Grey placed on leave over sexual harassment allegations
Aubrey de Grey, the jet-setting gerontologist who co-founded the SENS Research Foundation to discover ways…
STAT+: Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices
WASHINGTON — Five of the most vulnerable Democrats in the Senate on Tuesday publicly renewed…
STAT+: Veterans Affairs declines to cover Biogen Alzheimer’s drug over effectiveness and safety concerns
The Department of Veterans Affairs has decided not to cover a new Alzheimer’s drug from…
STAT+: Pharmalittle: WHO to lead trial testing three drugs as Covid-19 salves; patient access to antibiotics lacking in wealthy countries
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…